Abstract
Objective
To study the excipients exposure among neonates in a neonatal intensive care unit.
Method
Prospective observational study was conducted from January, 2017 to June, 2019. Details of administered drugs were collected from the hospital case files. List of excipients of formulations and their quantities were collected from package insert leaflets or by contacting the manufacturers. Excipients were grouped into four categories based on available safety data. Calculated daily exposures to the excipients (mg/kg/day) were compared with adult acceptable daily intake.
Results
More than half of the included 746 neonates were exposed to harmful excipients. 12.3% and 12.7% of neonates received higher than acceptable daily intake of sodium metabisulphite and sunset yellow FCF, respectively.
Conclusion
There is a high risk of exposure of neonates to harmful excipients, and clinicians need to be aware of this during neonatal care.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lass J, Naelapää K, Shah U, Käär R, Varendi H, Turner MA, et al. Hospitalized neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr. 2012;12:136.
Whittaker A, Currie AE, Turner MA, Field DJ, Mulla H, Pandya HC. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F236–40.
Souza A Jr, Santos D, Fonseca S, Medeiros M, Batista L, Turner M, et al. Toxic excipients in medications for neonates in Brazil. Eur J Pediatr. 2014;173:935–45.
Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-Drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157–67.
Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med. 1982;307:1384–8.
Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients, 6th ed. Pharmaceutical press; 2009.
Commission of the European Communities. Report from the Commission on Dietary Food Additive Intake in the European Union. Available from: https://ec.europa.eu/transparency/regdoc/rep/1/2001/EN/1-2001-542-EN-F1-1.Pdf. Accessed January 10, 2019.
European food safety authority (EFSA). Reasoned opinion on the dietary risk assessment for proposed temporary maximum residue levels (MRLs) of didecyldimethy-lammonium chloride (DDAC) and benzalkonium chloride (BAC). Available from: https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2014.3675. Accessed January 13,2019.
European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Reflection Paper: formulations of choice for the paediatric population. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf. Accessed December 12, 2018.
Fister P, Urh S, Karner A, Krzan M, Paro-Panjan D. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia. J Matern Fetal Neonatal Med. 2015;28:2053–61.
Garcia-Palop B, Movilla Polanco E, Cañete Ramirez C, Cabañas Poy MJ. Harmful excipients in medicines for neonates in Spain. Int J Clin Pharm. 2016;38:238–42.
Akinmboni TO, Davis NL, Falck AJ, Bearer CF, Mooney SM. Excipient exposure in very low birth weight preterm neonates. J Perinatol. 2018;38:169–74.
Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, Lega L, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics. 2012;129:e40–5.
Committee on Fetus and Newborn, Committee on Drugs. Benzyl Alcohol: Toxic Agent in Neonatal Units. Pediatrics. 1983;72:356–8.
Hiller JL, Benda GI, Rahatzad M, Allen JR, Culver DH, Carlson CV, et al. Benzyl alcohol toxicity: Impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics. 1986;77:500–6.
CDC. Neonatal deaths associated with use of benzyl alcohol-United States. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm. Accessed August 13, 2018.
Van Riet-Nales DA, de Jager KE, Schobben AF, Egberts TC, Rademaker CM. The availability and age-appropriateness of medicines authorized for children in the Netherlands. Br J Clin Pharmacol. 2011;72:465–73.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ethical clearance
VIPS Human Ethics Committee; IEC/2016-14 dated December 09, 2016.
Contributors
SN: collected the data, analyzed the data and wrote the manuscript; NKM: designed, monitored and supervised the study and approved the final manuscript; SB: was the neonatologist who co-supervised the study.
Funding
None
Competing interest
None stated.
Rights and permissions
About this article
Cite this article
Nasrollahi, S., Meera, N.K. & Boregowda, S. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit. Indian Pediatr 57, 801–804 (2020). https://doi.org/10.1007/s13312-020-1956-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1956-x